Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.3B | 8.1B | 7.8B | 8.2B |
Cost of revenue | 5.2B | 5.8B | 5.5B | 5.8B |
Gross profit | 2.1B | 2.2B | 2.2B | 2.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 827.3M | 607.0M | 1.0B | -1.2B |
Operating income | 1.4B | 1.8B | 1.3B | 1.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 591.2M | 615.1M | 601.2M | 615.8M |
Other income expense | — | — | — | — |
Pretax income | 986.7M | 1.3B | 899.2M | 1.3B |
Tax provision | 251.3M | 277.3M | 249.2M | 181.4M |
Net income | 735.4M | 1.0B | 650.0M | 1.1B |
Basic EPS | 0.0 | 0.1 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.1 | 0.0 | 0.0 |
Basic average shares | 11.0B | 11.0B | 11.0B | 11.0B |
Diluted average shares | 11.2B | 11.2B | 11.2B | 11.2B |
EBITDA | 2.2B | 2.5B | 2.1B | 2.3B |
Net income from continuing op. | 986.7M | 1.3B | 899.2M | 1.3B |
Minority interests | -316.0M | -438.8M | -316.3M | -549.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |